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 Introduction  
Membrane proteins make up to 30% of all proteins coded for by most genomes 1 and they 
facilitate a wide range of cellular functions for the cell and are a means by which the cell 
communicates with its environment. They are popular drug targets for the pharmaceutical 
industry.2 There is also an increasing family of antimicrobial peptides that bind to lipid 
membranes.3 The mechanism by which such antimicrobial peptides act has become a complex 
issue. It is widely accepted that it is important to understand how the peptides act in order to 
fully exploit the use of peptides as antimicrobial agents.4 However, the techniques that have been 
so successfully applied to understand structural questions for globular proteins, including 
crystallography and NMR, are not as readily applied for the study of membrane proteins. 
Membrane proteins and peptides are not easy to crystallize and they usually require lipid or 
detergent environments to remain soluble and folded. Although progress is being made with 
solution and solid-state NMR the size of the membrane protein-detergent complexes usually 
results in slow tumbling rates and poor resolution spectra with broad peaks. The other side of the 
membrane protein-membrane interaction system is the lipid bilayer itself. We currently know 
very little about how membrane-binding drugs interact with cell membrane lipids. The aim of 
this work is to explore both sides of this question for the bee venom peptide melittin. By using 
flow linear dichroism of liposomes a perspective on membrane peptide-membrane interactions 
becomes available that is not available from any other technique. 
Linear dichroism (LD), although not an atomic-level resolution technique, has been 
found to be ideally suited to membrane environments. Linear dichroism is the differential 
absorbance of light polarized parallel and perpendicular to an orientation axis. A non-zero signal 
requires an oriented sample to have absorbance bands in a given region of the spectrum. 
Following the discovery by Ardhammar et al.5 that model membranes, known as liposomes, 
become sufficiently distorted in shear flow to become aligned, together with any molecules 
bound to the lipid, we showed that membrane peptides and proteins could be flow aligned when 
bound to liposomes.6, 7 As has been illustrated in subsequent work, one can qualitatively and 
quantitatively identify the orientation of membrane guest molecules, provided that the molecules 
of interest have significant absorption in the UV-Visible region. One can also measure insertion 
kinetics in real time to give insight into peptide folding and insertion in membranes.8-12 In 
solution, LD has the advantage over other biophysical techniques of being insensitive to off-
membrane events—unbound ligands or peptides are invisible as they do not orient.  
LD is the ideal technique for probing insertion / binding (or not) into / onto membranes in 
real time since the signal is zero unless the analyte (for example a peptide) binds to the 
membrane, and an alpha helical peptide on the surface has opposite signed LD signals to when it 
is inserted as summarized in Figure . 
 
 
Figure   Schematic illustration of expected LD signals for an α-helix on the surface of or inserted 
in a membrane.  
 
The peptide of interest in this work, melittin, is an amphiphilic and cationic peptide. It is 
a 26 amino acid residue peptide with a positively charged C-terminus and a proline residue at 
position 14 that allows it to form kinked helices in non-polar environments.13 Its secondary 
structure changes from random coil in aqueous solutions to helical in membranes.14 At low 
concentration is in a monomeric conformation, whereas at higher concentrations it forms 
tetramers in aqueous solution.14, 15  
Melittin (Figure 2) is an interesting peptide in its own right, being a main component of 
bee venom and also having anti-microbial properties.16 In addition it is a popular model peptide 
for studying cytolytic activities on both eukaryotic and prokaryotic cell membranes. Melittin is 
known to bind to membranes to form pores, although the mechanism by which it disrupts the 
membranes is still a matter of debate. Papo and Shai concluded that melittin binds on surface of 
a membrane or in a transmembrane manner via a carpet-like or barrel-stave mechanism 
depending on whether it is driven by a combination of hydrophobic or electrostatic effects.17 Van 
den Bogaart et al. have studied the mechanism of pore formation of melittin in membranes made 
 
from the lipids 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dioleoyl-sn-glycero-
3-[phospho-rac-(1-glycerol)] (DOPG). They concluded that melittin caused pore formation in 
DOPC membranes but not those made of DOPG.18 Most recently Manna et al. concluded from 
modeling that in 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) membranes melittin 
forms pores in the membrane by the toroidal mechanism.19 The peptide’s behaviour in 
membranes depends on many variables such as the concentration of the peptide, the composition 
and phase of the lipid membrane or even the solvents and buffers used to carry out the 
experiments.  
(a) NH2-GIGAVLK+VLTTGLPALISWIK+R+K+R+QQ-CONH2 
 
(b)  
 
 
 
 
  
 
 
Figure   (a) Sequence of melittin. (b) Structures of lipids of relevance to this work: DMPC, myristic acid, 
lyso PC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC), 1,2-dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DPPG), 1,2-dipalmitoyl-
sn-glycero-3-phosphocholine (DPPC). 
 
In bee venom, melittin is always accompanied by the enzyme phospholipase A2 (PA2). 
Melittin and PA2 are known to act synergistically on cell membranes: melittin enhances the 
movement of anions in membranes and lyses cells at high concentration, this is facilitated by the 
lipolytic activity of PA2 which catalyses the hydrolysis of the sn-2 ester bond of lipids in the 
presence of Ca2+.20 Conversely, melittin enhances the rate of hydrolysis by perturbing the lipid 
bilayer and reorienting the sn-2 ester bond. Of particular relevance to this work, PA2 is known to 
hydrolyse the lipid 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC, Figure 1) to form lyso 
MPC and myristic acid.21  
In this work we have used LD, complemented by other spectroscopic techniques as well 
as dynamic light scattering (DLS) and MALDI mass spectrometry, to probe the behaviour of 
melittin inserting into different membrane-mimicking lipid environments and to consider the 
effect of the enzyme PA2 on that process. The lipids vary in their acyl chain length, degree of 
unsaturation and charge. By complementing LD with a range of other biophysical techniques 
including circular dichroism (CD), MALDI-MS, thin layer chromatography (TLC), DLS and 
oriented CD (OCD) we have been able to follow the folding and insertion process of melittin 
into membranes in real time and to understand key aspects of the process. Most of the work has 
been undertaken with melittin co-purified with trace amounts of PA2 present (<0.05 U/mg), 
denoted melittinPA2. However control experiments on isolated melittin (melittinpure), 
phospholipase A2, and a controlled mixture of the two have also been undertaken.  
 Materials and methods 
 Materials  
Melittin from bee venom was purchased from Sigma-Aldrich (Dorset, UK). This melittin 
is co-purified with PA2 (<0.5 U/mg). Bis-tris propane (B6755) CH2[CH2NHC(CH2OH)3]2 was 
purchased from Sigma-Aldrich. Its pH was adjusted with diluted hydrochloric acid. DMPC, 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC), 1,2-dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DPPG), 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1-palmitoyl-2-docosahexaenoyl-sn-
glycero-3-phosphocholine (PDPC) were purchased from Avanti polar Lipids, Alabama, USA. 
All other chemicals were obtained from Sigma-Aldrich. 
 Methods 
 Liposome preparation 
A stock solution of 2.5 mg/mL small unilamellar vesicles (SUVs) was prepared by 
dissolving the lipid (or lipids) in either 2,2,2-trifluoroethanol (DMPC) or chloroform (the 
remainder). The sample was then dried under nitrogen flow and placed under vacuum overnight 
to remove residual organic solvent resulting in a lipid film on the inner surface of the container. 
The lipid film was then suspended in 10 mM bis-tris propane (BTP, 10 mM, pH 7) and 
freeze/thawed five times using dry ice/ethanol and room temperature (RT) for DMPC, DOPC, 
POPC and PDPC and dry ice/ethanol and 37 °C for DPPC, DPPG, POPC/DPPG. The lipid 
samples were then extruded 11 times through a 100 nm polycarbonate membrane, at 
temperatures similar to those used during the thawing process to create nominal 100 nm 
liposomes (the actual size of the liposomes is larger once they relax following extrusion as 
discussed below).  
 Peptide solutions 
The peptide was dissolved in water to produce stock solutions of 5 mg/ml. Experiments 
were all undertaken at lipid:peptide molar ratio of 100:1 and peptide concentration of 0.1 
mg/mL. Samples were prepared by adding the appropriate volume of the peptide stock solution 
to a buffered solution of liposomes. 
 Spectroscopy 
CD spectra were collected in a 0.5 mm path length quartz demountable cell in a Jasco 
(Great Dunmow, UK) J-815 CD spectropolarimeter. LD spectra were collected using a Jasco J-
815 spectropolarimeter adapted for LD measurements in a microvolume Couette flow cell 
manufactured by Crystal Precision Optics, Rugby, UK and now available via Kromatek Ltd., 
(Great Dunmow, UK).7, 10-12, 22-26 Far UV CD and LD spectra (190–320 nm) were collected using 
a data pitch of 0.2 nm, continuous scanning mode, scanning speed of 100 nm/min, response of 1 
s, band width of 1 or 2 nm. The Couette cell rotation speed was ~3000 rpm (setting: 3.0 V). 
Fluorescence spectra were collected using a Jasco FP-6500 fluorimeter using excitation 
wavelength 280 nm, with 3 nm bandwidth for excitation and emission, and 3 mm path length 
microvolume cuvettes (Starna Hainalt, UK). DLS data were collected using a Malvern Zetasizer 
Nano S (Malvern Instruments, Malvern, UK) and the 3 mm path length microvolume 
fluorescence cuvette. Samples for OCD were deposited on a flat cylindrical quartz cuvette and 
allowed to dry overnight before being inserted into the light beam with the light beam incident 
perpendicular to the plane of the quartz. 
 MALDI 
MelittinPA2 was added to DMPC liposomes in 10 mM bis-tris propane (pH 7) in the 
absence of EDTA, and 1 µl aliquots were removed every 30 seconds and immediately mixed 
with a solution of 2,5-dihydroxybenzoic acid (DHB) matrix (9 µl, 10 mg/ml, water/0.1% TFA). 
The addition to the matrix solution was found, in preliminary previous experiments, to quench 
the hydrolysis-catalysing effect of the enzyme PA2. Two aliquots of 0.6 µl of each sample were 
spotted on separate positions on the MALDI target plate. MALDI-MS spectra were recorded, 
using a Ultraflex II MALDI-TOF/TOF spectrometer with 337 nm nitrogen laser (Bruker 
Daltonics Ltd., Coventry, UK) for each aliquot the intensity of the peak corresponding to lyso-
MPC was normalized relative to that of the sum of the peaks corresponding to lyso-MPC and the 
[DMPC + H]+ molecular ion. Data were averaged over 4000 laser shots from each spot. The 
error bars correspond to two times the standard deviation of the data from the two spots. 
 Results 
We first consider the secondary structure of melittin in a range of lipids. An analysis of 
data collected during the binding of melittin with DMPC liposomes is then followed by an 
overview of its behaviour with a range of other lipids. The key properties of the lipids used in 
this work are summarized in Table . The variables include charge and unsaturation as well as 
chain length.  
 Table   Properties of lipids used in this work, the orientation of melittin on or in the liposome, and 
the ratios of the melittin CD signals at 222 nm and 208 nm. The notation 18:2 denotes a lipid tail 
length of 18 carbons with 2 unsaturated bonds. DMPC at 25° C is very close to its phase transition 
temperature (23° C for pure DMPC) as denoted by the phase assignment of “transition”.  
 
Lipid Lipid charge 
And phase 
Degree of 
unsaturation 
Melittin Orientation 
on or in 
membrane 
CD222/CD208 Fluorescence 
maximum 
DOPC +/– (liquid) 18:1_18:1 MelittinPA2 In 1.4 336 
POPC +/– (liquid) 18:1_16:0 MelittinPA2 In 1.2 335 
80POPC:20DPPG – (liquid) 18:1_16:0/16:0 MelittinPA2 In 1.2 336 
DPPG – (gel) 16:0 MelittinPA2 In 0.96 333 
80DPPC:20DPPG – (gel) 16:0/ 16:0 MelittinPA2 In 1.04 335 
DPPC 37 °C +/– (liquid) 16:0 MelittinPA2 - 0.92 339 
DMPC 37 °C +/– (liquid) 14:0 MelittinPA2 In 1.05 338 
DMPC 25 °C LUV +/– (transition) 14:0 MelittinPA2 In 1.05 335 
DMPC 25 °C SUV +/– (transition) 14:0 MelittinPA2 In 0.99 335 
DMPC 37 °C +/– (liquid) 14:0 Melittinpure In 0.87 341 
DMPC 37 °C +/– (liquid) 14:0 Melittinpure+ PA2 In 0.96 342 
 Secondary structure of melittin 
Melittin is known to be unfolded in aqueous solution and to be folded into an α-helix 
when in the presence of any lipids for which the CD has been measured.27, 28 29,30-32 Melittin’s 
CD spectra in water and in lipid (DMPC) are illustrated in Figure a. The secondary structure of 
melittin in DMPC is established within the dead-time of loading the cuvette and remains 
unchanged thereafter (Figure b).  
In this work, for the first time, the effect of lipid unsaturation and lipid charge on the CD 
spectra of melittin has been investigated. The concentration of PA2 in all samples was so low 
that it makes no direct contribution to the CD spectra. As shown in Figure c, the melittin CD 
spectra are all indicative of it having a helical conformation and they are very similar in 
magnitude, but vary slightly in shape as a function of lipid composition of the membrane. The 
intensity of the CD spectra of melittin at 222 nm are larger than those at 208 nm when melittin is 
inserted (see below for proof of insertion by LD) in membranes made of unsaturated lipids and 
conversely for saturated lipids, as summarized in Table . The CD222/CD208 ratio is associated in 
the literature with the hydrophobicity of the environment of a helical peptide (originally 
methanol versus lipid)33 as well as its oligomeric state (oligomerisation presumably also 
providing a more hydrophobic environment). For example, larger CD222/CD208 ratios have been 
deemed to indicate membrane insertion or oligomerisation.34, 35 Although this has not been 
proven, the idea is sufficiently widely used that we can conclude it is consistent with most data 
that have been collected. Our results therefore imply that the unsaturated lipids provide a more 
hydrophobic environment for melittin. In support of this, the fluorescence maximum of 
melittin’s tryptophan shifts to lower wavelength (which also implies a more hydrophobic 
environment) with increasing lipid unsaturation (Table ). It therefore follows that increasing 
unsaturation enables the lipids to pack about the helix more effectively. We attribute this effect 
to membrane flexibility and packing. Consistent with this, melittin with PA2 and melittin with 
mixed lipids (all where the membrane is more flexible) have higher CD222/CD208 ratios. We 
return to this issue below.  
There is one report in the literature of melittin becoming a β-sheet in a lipid with 6 
double bonds, 1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine (PDPC). The 
observed loss of the CD signal at 208 nm that has been attributed to a β-sheet structure,36 is 
almost certainly a spectral artifact, as the published spectrum is actually closer to that expected 
for an α-helix 24 combined with the artifacts that arise from the saturation of the photomultiplier 
tube.37 To confirm this is actually the case we measured the CD spectrum of melittin when added 
to PDPC liposomes and after 20 hours. Both spectra are clearly α-helical, though with the 
highest 222 nm/208 nm ratio which supports the above conclusion about hydrophobic 
environment being provided by unsaturated lipids. Infra red data (not shown) confirm the lack of 
β structure for melittin with this lipid. 
  
  
 
Figure   CD spectra of melittin (0.1 mg/mL) in 0.5 mm path length cuvettes as a function of lipid 
environment (lipid:melitin molecular ratio 100:1). (a) MelittinPA2 in DMPC and water at 25°C. (b) 
MelittinPA2 in DMPC at 25°C as a function of time. (c) Melittin in different lipids and temperatures 
(as indicated in the figure). Melittin is melittinPA2 unless otherwise indicated. (d) Melittinpure in 
PDPC .  
 Interaction of melittinPA2 and melittinpure with DMPC 
Our aim, for the first time, was to probe the insertion of melittin into lipid biplayers in 
aqueous solution in real time. As shown in Figure , at time zero (when the melittin is already 
helical as shown by CD, Figure a) at both 25°C and 37°C, for melittinPA2 and DMPC liposomes, 
LD~0. After a few minutes at both temperatures a positive LD signal is apparent in the region of 
224 nm and 192 nm. The minimum at 210 nm is in fact the negative signal from the long 
wavelength component of the π-π* transition (Figure ). Since α-helix transitions at 222 nm and 
192 nm are polarized perpendicular to the helix axis and that at 210 nm is polarized parallel to 
the helix axis,22 and since for liposome-bound chromophores 5, 22 
 where S is the orientation parameter, β is the angle between a transition moment and the normal 
to the bilayer surface and Aiso is the isotropic absorbance of the sample (i.e. the unaligned 
sample), it follows that the melittin is inserting into the bilayer after the first few minutes with 
either its orientation becoming more parallel to the membrane normal as time goes on or more 
melittin inserting.  
 Given that the α-helical CD signature of melittin with DMPC tells us that it is membrane 
associated (see above) from the beginning of the LD experiment, it is intriguing that the initial 
LD is zero. If the melittin α-helix is lying flat on the surface then its LD sign pattern should 
simply be approximately opposite from that observed at later time as illustrated in Figure . The 
only other option for having LD=0 is that the dominant 222 nm and 192 nm bands are oriented 
with transition moments having average orientation close to the magic angle β=54.7°. Since 
melittin is known to kink at its central proline, the LD therefore suggests that the kink angle is 
~110° as illustrated in Figure . 
 
Figure   Schematic illustration of melittin (bold lines) bound on the surface of the liposome with 
the backbone lying at the magic angle to the membrane normal. 
 
 The insertion kinetics of melittin with DMPC liposomes are much faster at 25°C than at 
37°C (Figure ). Further, by t=6 minutes the 25°C melittin LD is back to zero, whereas the 37°C 
signal begins to decrease only after hours. The reason for the LD at 25 °C having vanished by 
t=6 minutes is apparent from the DLS data (Figure 6a): the average vesicle size increases from 
its initial value of about 180 nm to 240 nm at 3 minutes and then dramatically drops to 25–35 nm 
These particles are too small or too rigid to orient in the Couette flow. The 37°C data, by way of 
contrast, shows a gradual increase in LD and no micellisation. The DMPC liposomes alone 
remain the same size over time, measured using DLS (data not shown). The oriented CD spectra 
of Figure b, measured on a 25°C sample collected at the conclusion of its kinetic process and 
then dried onto a flat surface, show that the melittin is still inserted into the bilayer in a trans-
membrane orientation (the 208 nm band is attenuated compared with the spectra of Figure  and 
the 192 nm band shifts to longer wavelength).37  
Performing the LD/DLS experiment at other temperatures (21° C, 25° C, 29° C, 35° C and 
37° C, data not shown) indicated that at the lower temperatures rapid fusion of liposomes 
followed by lipid micellisation occurs yet at 35° C and 37° C only gradual fusion of the 
liposomes occurs. The DMPC phase transition is at 23° C so near the phase transition is where 
we observe micellisation to occur. It is somewhat counter-intuitive that the insertion is faster in 
the more rigid lower temperature environment. We return to this below. 
 
  
   
 
Figure   LD of melittinPA2 (0.1 mg/mL) when added to DMPC liposomes (at molar ratio of lipid: peptide of 
100:1) at (i) 25 °C and (ii) 37°C. (a) Wavelength scans. (b) Data plotted as a function of time at selected 
wavelengths.  
 
  
Figure   (a) DLS of DMPC liposomes after addition of melittinPA2 (0.1 mg/mL) (at molar ratio of 
lipid: peptide of 100:1) at 25 °C and 37°C. (Note log scale on x-axis.) (b) OCD of the 25°C sample at 
the end of the kinetics after the water has been evaporated.  
 The role of PA2 in melittin insertion kinetics 
Since it is known that PA2 hydrolyses lipids and since we see a change (albeit small) in 
the CD spectrum of melittin with and without catalytic amounts of PA2, we were interested to 
see how PA2 affected the insertion kinetics of melittin. The data of Figure  and Figure  show 
that the same kind of insertion and liposome growth occurs for both melittinPA2 and melitinpure, 
however, it is all noticeably slower and smaller for melittinpure at 25°C. At 37°C the kinetics are 
comparable for both melittinPA2 and melittinpure. though melittinPA2 achieves a higher magnitude 
LD signal. There is no evidence of micellisation on an hours to days timescale at either 25°C or 
37°C with melittinpure. When we added PA2 (at the upper bound of that present in melittinPA2 
from Sigma) to melittinpure, then the rates/intensities observed with melittinPA2 were recovered 
(or indeed exceeded). 
We also investigated the effect of PA2 on DMPC liposomes. The DLS data of Figure c 
show that PA2 alone does disrupt the liposomes at 25°C, however, the time takes about twenty 
times longer than that of the combined melittin/PA2 preparation. There was no PA2 LD or CD 
evident in this sample due to the low protein concentration of PA2. 
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Figure  (a) LD and (b) DLS of melittinpure (0.1 mg/mL) in DMPC (at molar ratio of lipid: peptide of 
100:1) at (i) 25°C and (ii) 37°C. (c) DLS of DMPC liposomes with PA2 (0.05 Units) at different 
temperatures.  
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To determine how the PA2-catalysed DMPC hydrolysis affected melittin interaction with 
DMPC liposomes we adapted a TLC method taken from the Avanti web site and developed a 
MALDI methodology to follow any changes in the lipids during the insertion reaction. We first 
established that both the TLC plate and the MALDI matrix (DHB) quenched the enzyme-
catalyzed hydrolysis of DMPC, so it was a straightforward matter to sample a reaction at 
different time-points and measure the lipid content. As shown in Figure  the intensity of the 
DMPC signal reduces and that of lysoPC grows at compensating rates. The TLC results confirm 
the MALDI data (data not shown). At about t=6 minutes (where the intensities of the DMPC and 
lysoPC peaks are comparable) the liposomes fragment into smaller particles. Not surprisingly, 
the LD signal is maximum just before this time point.  
EDTA is known to suppress the activity of PA2.21 Addition of EDTA (2 mM) to the 
DMPC/melittinPA2 reaction mixture slowed down the whole process (insertion and membrane 
disruption) to a timescale of tens of hours.  
 
 
Figure  MALDI analysis of the lipids present after melittinPA2 was added to DMPC liposomes. 
Experimental details are as for Figure . Timepoints are indicated on the figure. 
 
There is evidence in the literature that PA2 activity increases when there are more defects 
in the membrane,ref??? John i.e. close to the transition temperatures and/or induced by melittin 
binding, especially in the gel phase).38 This would make the activities of PA2 and melittin 
synergistic. The activity of PA2 is generally low??? on saturated membranes on either side of the 
transition temperature. It is somewhat counter-intuitive that the insertion is faster in the more 
rigid lower temperature environment, but this may be the underlying reason.  
 Melittin insertion as a function of lipid composition 
Biological membranes are made predominately of sn-1 saturated, sn-2 unsaturated acyl 
chains or even of phospholipids with two polyunsaturated acyl chains. Phospholipids with 
polyunsaturated acyl chains are known to influence membrane dynamics.39, 40 Further, it has 
been shown that the degree of unsaturation of a membrane modulates the membrane-disruption 
action of melittin (lytic power and bilayer micellisation).36 This has been claimed to be at least in 
part due to the secondary structure of melittin changing with the membrane. However, as 
discussed above, their observed increase in the 222 nm CD band is more likely to be due to 
better packing of the hydrophobic phase. We therefore chose to consider the effect of melittinPA2 
on a range of lipids formed into liposomes. 
DLS showed us a first difference between the lipids, namely that the vesicles made from 
unsaturated lipids by extruding through a 100 nm polycarbonated membrane were approximately 
twice the size of those made from saturated vesicles (which were ~110 nm). This reflects the 
greater flexibility of the unsaturated lipid vesicles operating during the extrusion process. 
The maximum LD signals, obtained after the time indicated in the figure, are shown in 
Figure . From the data it can be concluded that the orientation of melittin is similar in all the 
systems studied. Although the unsaturated lipids have slightly larger signals, as their lipids are of 
higher molecular weight and the sample viscosity is somewhat higher we cannot ascribe any 
significance to this. Another key parameter is how quickly that maximum signal is obtained. The 
peptide adopts its maximum LD signal in the order indicated in Table . Somewhat surprisingly 
the slightly higher temperature but still less flexible saturated gel-phase membranes obtain 
maximum transmembrane orientation (LD maximum) more quickly than the unsaturated more 
flexible ones. Addition of negative lipids speeds the process up for the saturated lipids whereas it 
slows it down further for the unsaturated one. Pure DPPC (Table 2, Figure ) shows no insertion. 
Overall, the LD data suggest that flexibility of the membrane slows down the insertion process 
but the end product is better oriented.  
Not only does the membrane provide an environment for the peptide, it is also affected 
by the peptide as summarized in Table . Two competing perturbations to the membranes occur: 
fusion and micellisation. Negative charge and unsaturation increase the tendency for the 
liposomes to grow (presumably by fusion) in size whereas saturation (or more rigid membranes, 
e.g. the gel phase of DMPC) favours membrane micellisation. However, this conclusion is over 
simplistic since POPC with one double bond is dominated by micellisation.  
 
 
Table   Summary of kinetic data for melittin as a function of lipid properties. Ranking is as 
follows: 0 denotes none; 1 denotes least flexible/rate of insertion/micellisation/fusion; 2 denotes 
slightly more etc. 
 
 DOPC POPC/DPPG POPC DMPC 
37° 
DPPG DMPC 
25oC 
DPPC/DPPG DPPC 
 18:1_18:1 18:1_16:0/16:0 18:1_16:0 14:0 16:0 14:0 16:0/16:0 16:0 
Estimate of 
membrane 
flexibility 
8 7 5 5 1 2 2 2 
Negative 
charge 
0 1 0 0 2 0 1 0 
LD intensity 7 3 2 4 5 6 1 0 
Rate of 
insertion 
1 2 3 4 5 6 7 0 (no 
LD) 
Micellisation 0 0 1  0 3 2 4 
Fusion 3 4 2  0 1 0 5 
 
 
  
 
Figure  Maximum LD spectra obtained for melittinPA2 (0.1 mg/mL) added to liposomes at 
lipid:peptide ratio of 100:1. Times and lipids are indicated on the figure.  
 Conclusion 
For the first time, in this work, flow aligned linear dichroism has been applied to study 
the orientation of melittin in the membrane-mimicking environment of a liposome. It is the ideal 
technique for such real-time measurements. Overall, the pattern is a very complicated molecular 
process even for a simple peptide such as melittin, however, LD helps one clearly identify when 
insertion is happening which improves our ability to analyse peptide/membrane interactions. 
However, LD does not stand on its own and needs to be complemented by a range of other 
biophysical techniques. 
Melittin is co-purified from bee venom with phospholipase A2. They were known to 
affect each other’s behaviour. We developed TLC and MALDI methods from those available in 
the literature to follow the lipid kinetics in parallel with the LD experiments. We found that PA2 
speeded up the insertion of melittin (as measured by the increase of the LD signal) and also 
speeded up any membrane disruption that melittin induces. Similarly, melittin speeds up the 
phospholipase action of PA2. However, by comparing melittin co-purified with phospholipase 
A2, pure melittin and pure melittin doped with phospholipase A2 we concluded there was no 
other difference in behaviour. We therefore focused our analysis on melittin with catalytic 
amounts of the enzyme as a more representative sample of the action of native melittin. 
For the first time we have surveyed the behaviour of melittin with a range of lipids. 
Overall our conclusions about melittin are that melittin is helical with all the lipids studied, 
though random coil in aqueous solution. When added to liposomes it rapidly folds and then 
inserts more or less parallel to the membrane normal. The membrane insertion behaviour of 
melittin varies with lipid and membrane phase. In general terms, the insertion is faster with more 
rigid lipids but generally reaches a higher level (as indicated by LD magnitude) with less rigid 
lipids. Inclusion of 20% negatively-charged lipids affects the insertion, speeding the process up 
for the saturated lipids but slowing it down further for the unsaturated one. We detected no 
insertion with the liposomes made from 100% of the long chain saturated lipid DPPC. Any 
assessment of insertion effectiveness is affected by how the melittin is perturbing the membrane: 
it can induce both fusion and micellisation—the latter leading to no LD while retaining insertion 
into the membrane. Saturated lipids are more prone to micellisation. 
The mechanistic conclusions to be deduced from this work relate to the 
insertion/fusion/micellation properties of melittin with a range of lipids, which suggest a 
mechanism whereby melittin in collaboration with phospholipaseA2 acts on membranes to insert 
and then degrade the lipids to facilitate micellisation. This will enable the melittin to be recycled 
to affect more membranes than the initial target. These observations are consistent with the 
recent realization that the way many cationic amphiphilic drugs work is by catalysing the 
chemical degradation of the phospholipid fabric of plasma membranes. Melittin as with other 
peptides thus does not simply interact passively with cellular membranes as postulated by current 
drug translocation mechanisms, rather it is an active physical and chemical process.20, 41, 42  
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